HELX | Franklin Genomic Advancements ETF Overview

(Stock Exchange: BATS)

Day's Range	N/A - N/A
52 Week Range	N/A - N/A
Beta	1.06
Implied Volatility	26.40%
IV Rank	21.23%
Day's Volume	N/A
Average Volume	N/A
Shares Outstanding	N/A
Inception Date	2020-02-27

Assets	9,699,000
Asset Class	Equity
Expense Ratio	0.50
P/E Ratio	N/A
EPS	N/A
Dividend Yield	0.01%
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

*Chart delayed

Watching at HELX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on HELX Technicals page.